Literature DB >> 16169346

Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation.

Kei Inai1, Toshio Nakanishi, Makoto Nakazawa.   

Abstract

AIMS: We tested the hypothesis that neurohumoral activation could correlate with exercise tolerance and have a prognostic value in patients late after Fontan operation. METHODS AND
RESULTS: We studied 50 consecutive patients after the Fontan operation and 10 age-matched normal controls. We measured brain and atrial natriuretic peptides, norepinephrine (NE), plasma rennin activity, aldosterone, angiotensin II, and endothelin and investigated the relationship of neurohumoral factors with exercise tolerance and central hemodynamics. We also evaluated the prognostic predictive value of these factors. All factors were significantly higher in the patients than in controls, but no factor correlated with peak oxygen consumption (peak VO2). There were significant correlations of atrial natriuretic peptide with cardiac index, NE with left ventricular ejection fraction (LVEF), and pulmonary arterial wedge pressure. After 4 years' follow-up, univariate Cox proportional hazards analysis showed that peak VO2 and LVEF could significantly predict the long-term event-free ratio. In multivariate analysis, LVEF and NE have a significant predictive value. In Kaplan-Meier event-free curves, NE combined with peak VO2 showed a significant predictive value.
CONCLUSIONS: Activated neurohumoral factors are not determinants of exercise tolerance in patients late after the Fontan operation. The plasma level of NE combined with peak VO2 has a prognostic predictive value in these patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169346     DOI: 10.1016/j.ahj.2004.10.030

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  18 in total

Review 1.  The Lymphatic Circulation in Adaptations to the Fontan Circulation.

Authors:  Sabarinath Menon; Murthy Chennapragada; Shinya Ugaki; Gary F Sholler; Julian Ayer; David S Winlaw
Journal:  Pediatr Cardiol       Date:  2017-02-16       Impact factor: 1.655

2.  Mechanisms of systemic adaptation to univentricular Fontan conversion.

Authors:  Cynthia D Myers; Kimberly Ballman; Lindsay E Riegle; Kelly D Mattix; Kenneth Litwak; Mark D Rodefeld
Journal:  J Thorac Cardiovasc Surg       Date:  2010-05-18       Impact factor: 5.209

3.  Clinical research priorities in adult congenital heart disease.

Authors:  Timothy Cotts; Paul Khairy; Alexander R Opotowsky; Anitha S John; Anne Marie Valente; Ali N Zaidi; Stephen C Cook; Jamil Aboulhosn; Jennifer Grando Ting; Michelle Gurvitz; Michael J Landzberg; Amy Verstappen; Joseph Kay; Michael Earing; Wayne Franklin; Brian Kogon; Craig S Broberg
Journal:  Int J Cardiol       Date:  2013-12-24       Impact factor: 4.164

4.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.

Authors:  Candice K Silversides; Omid Salehian; Erwin Oechslin; Markus Schwerzmann; Isabelle Vonder Muhll; Paul Khairy; Eric Horlick; Mike Landzberg; Folkert Meijboom; Carole Warnes; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

Review 5.  Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.

Authors:  Werner Budts; Jolien Roos-Hesselink; Tanja Rädle-Hurst; Andreas Eicken; Theresa A McDonagh; Ekaterini Lambrinou; Maria G Crespo-Leiro; Fiona Walker; Alexandra A Frogoudaki
Journal:  Eur Heart J       Date:  2016-01-18       Impact factor: 29.983

6.  Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles.

Authors:  Kenji Miyamoto; Daiji Takeuchi; Kei Inai; Tokuko Shinohara; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2016-02-08       Impact factor: 2.037

Review 7.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

8.  Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study.

Authors:  Bradley A Maron; Alexander R Opotowsky; Michael J Landzberg; Joseph Loscalzo; Aaron B Waxman; Jane A Leopold
Journal:  Eur J Heart Fail       Date:  2012-10-30       Impact factor: 15.534

9.  Clinical Significance of Central Venous Pressure During Exercise After Fontan Procedure.

Authors:  Seiji Asagai; Kei Inai; Eriko Shimada; Gen Harada; Hisashi Sugiyama
Journal:  Pediatr Cardiol       Date:  2019-11-11       Impact factor: 1.655

10.  Plasma brain natriuretic peptide and systemic ventricular function in asymptomatic patients late after the Fontan procedure.

Authors:  Bik-Ling Man; Yiu-Fai Cheung
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.